The findings, led by scientists at the University of Sydney's Brain and Mind Centre, suggest that disrupted sleep-wake patterns could play a more central role in certain forms of depression than previously recognised. The proposed subtype is characterised by irregular sleep schedules, persistent morning fatigue and a tendency to stay awake late into the night, making it difficult to fall asleep or wake up at conventional times.
People who matched the profile were more likely to develop depression earlier in life, experience more severe symptoms and report a weaker response to standard antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) and serotonin-noradrenaline reuptake inhibitors (SNRIs).
The research could help explain why standard depression treatments do not work equally well for everyone experiencing the condition. It also points to potential treatment approaches that focus on the body's biological clock, including timed light exposure, consistent sleep schedules and medications that target the melatonin system. These approaches could be particularly relevant for people whose natural sleep schedules are delayed.
However, researchers have emphasised that the findings are an early step rather than a definitive change in how depression is diagnosed or treated. Circadian depression is not yet an officially recognised diagnosis, and experts say the results need independent confirmation. The proposed subtype also shares several characteristics with existing forms of depression.
Circadian depression refers to a proposed form of depression associated with disruptions to the body's circadian rhythm, the internal 24-hour clock that regulates sleep, wakefulness, eating patterns, hunger and mood. When this rhythm becomes misaligned, whether through consistently late bedtimes, repeated morning fatigue or frequently changing sleep schedules, sleep can become disrupted and depression may become more difficult to manage.
The researchers used six indicators to identify the proposed subtype: frequent late bedtimes, persistent morning grogginess, increased sleep during depressive episodes, symptoms that change with the seasons, a tendency to be a night owl and substantial differences between weekday and weekend sleep schedules. Participants who displayed at least three of these characteristics were classified as belonging to the circadian depression group.
The analysis drew on the Australian Genetics of Depression Study and included 11,380 adults with serious depression. Just over 2,600 participants met the criteria for the proposed subtype.
Compared with other participants, those in the circadian depression group tended to experience the onset of depression earlier in life and report more severe symptoms. Their experiences also included more suicidal thoughts, occasional manic-like spells and a greater likelihood of gaining weight during depressive episodes.
The researchers also identified higher genetic risks for several other conditions among these individuals, including attention-deficit hyperactivity disorder (ADHD), bipolar disorder, anxiety, insomnia and metabolic issues. However, the study does not establish that disruptions to circadian rhythms caused these risks, highlighting the complexity of the relationships between sleep patterns, genetics and mental health.
One of the study's notable findings concerned the effectiveness and tolerability of conventional antidepressants. Participants classified as having circadian depression reported that SSRI and SNRI medications were less effective and frequently caused more side effects.
These findings have prompted interest in approaches that target the biological clock, such as light therapy administered at specific times, adjustments to sleep routines and medications that influence the body's melatonin system. Such interventions could offer additional avenues for investigation among people whose sleep-wake cycles are consistently delayed.
However, the study did not test different treatments or compare their effectiveness in a clinical trial. It therefore cannot establish whether circadian-based therapies would work better than standard antidepressants for this group. Researchers have stressed that anyone considering changes to their medication should do so only under medical guidance.
Circadian depression also remains a proposed classification rather than a recognised mental health disorder. Experts caution that several of its defining symptoms overlap with established depression subtypes, including atypical depression. Sleep disturbances are also associated with conditions beyond depression, making it difficult to determine whether they represent a distinct subtype or a feature shared by multiple disorders.
The researchers acknowledge that the proposed criteria require testing in larger and more diverse populations. Independent studies will be needed to determine whether the classification consistently identifies a distinct group of patients and whether it can help guide treatment decisions.
For people living with depression, persistent exhaustion despite sleeping, difficulty maintaining conventional sleep hours or a pronounced night-owl pattern may be important details to discuss with a healthcare provider. The study suggests that these patterns could provide useful clues when assessing depression and considering treatment options.
Although further research is needed before circadian depression can be formally recognised or linked to specific treatment recommendations, the findings highlight the potential importance of sleep-wake patterns in understanding why depression affects people differently and why some patients report limited benefits from standard antidepressants
About The Author
Comment List